Page last updated: 2024-11-11

kukoamine a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

kukoamine A: inhibits Crithidia fasciculata trypanothione reductase; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5318865
CHEMBL ID79129
CHEBI ID81220
SCHEMBL ID16547596
MeSH IDM0253315

Synonyms (26)

Synonym
chebi:81220 ,
CHEMBL79129 ,
kukoamine a
n1,n2-bis(dihydrocaffeoyl)spermine
3-(3,4-dihydroxy-phenyl)-n-[3-(4-{3-[3-(3,4-dihydroxy-phenyl)-propionylamino]-propylamino}-butylamino)-propyl]-propionamide
bdbm50240622
C17615
3-(3,4-dihydroxyphenyl)-n-[3-[4-[3-[3-(3,4-dihydroxyphenyl)propanoylamino]propylamino]butylamino]propyl]propanamide
AC-34134
75288-96-9
SCHEMBL16547596
1,14-bis(dihydrocaffeoyl)spermine
AKOS032945995
Q27155166
FT-0686649
mfcd29904538
HY-N2392
CS-0022594
MS-29818
DTXSID401318256
9ym64fbw2r ,
3-(3,4-bis(oxidanyl)phenyl)-n-(3-(4-(3-(3-(3,4-bis(oxidanyl)phenyl)propanoylamino)propylamino)butylamino)propyl)propanamide
zinc-13513540
n1,n12-bis(dihydrocaffeoyl) spermine
n,n'-[1,4-butanediylbis(imino-3,1-propanediyl)]bis[3,4-dihydroxybenzenepropanamide]
benzenepropanamide, n,n'-[1,4-butanediylbis(imino-3,1-propanediyl)]bis[3,4-dihydroxy-

Research Excerpts

Overview

Kukoamine A (KukA) is a spermine (SPM) conjugate with dihydrocaffeic acid (DHCA), with interesting biological activities.

ExcerptReferenceRelevance
"Kukoamine A (KuKA) is a bioactive compound isolated from Lycium chinense which is known as its anti-inflammatory activity."( Kukoamine A protects mice against osteoarthritis by inhibiting chondrocyte inflammation and ferroptosis via SIRT1/GPX4 signaling pathway.
Ruan, Q; Sun, J; Wang, C; Zhang, Y, 2023
)
3.07
"Kukoamine A (KukA) is a spermine (SPM) conjugate with dihydrocaffeic acid (DHCA), with interesting biological activities. "( Kukoamine A analogs with lipoxygenase inhibitory activity.
Athanassopoulos, CM; Garnelis, T; Hadjipavlou-Litina, D; Papaioannou, D, 2009
)
3.24

Effects

ExcerptReferenceRelevance
"Kukoamine A (KuA) has the ability of anti-oxidative stress and anti-apoptosis in vitro."( Neuroprotective Effects of Kukoamine a against Radiation-induced Rat Brain Injury through Inhibition of Oxidative Stress and Neuronal Apoptosis.
Cheng, Z; Ma, H; Meng, W; Wang, C; Zhang, Y; Zhao, Q, 2016
)
1.45
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
amineA compound formally derived from ammonia by replacing one, two or three hydrogen atoms by hydrocarbyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Trypanothione reductaseTrypanosoma cruziKi0.07600.07605.15297.6000AID214484
Trypanothione reductaseCrithidia fasciculataKi7.40001.80001.80001.8000AID343382; AID343383
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID548961Antioxidant activity of the compound assessed as reducing activity of DPPH at 0.1 mM after 60 mins2010Bioorganic & medicinal chemistry, Dec-01, Volume: 18, Issue:23
Does conjugation of antioxidants improve their antioxidative/anti-inflammatory potential?
AID548956Inhibition of soybean lipoxygenase2010Bioorganic & medicinal chemistry, Dec-01, Volume: 18, Issue:23
Does conjugation of antioxidants improve their antioxidative/anti-inflammatory potential?
AID214484The compound was evaluated for inhibition of trypanothione reductase enzyme2000Bioorganic & medicinal chemistry letters, Oct-16, Volume: 10, Issue:20
Optimising inhibitors of trypanothione reductase using solid-phase chemistry.
AID548963Antiinflammatory activity in Fisher rat assessed as inhibition of carrageenan-induced paw oedema at 0.01 mmol/kg, po measured after 3.5 hrs2010Bioorganic & medicinal chemistry, Dec-01, Volume: 18, Issue:23
Does conjugation of antioxidants improve their antioxidative/anti-inflammatory potential?
AID343382Inhibition of Crithidia fasciculata free trypanothione reductase2008Bioorganic & medicinal chemistry, Jul-15, Volume: 16, Issue:14
The use of natural product scaffolds as leads in the search for trypanothione reductase inhibitors.
AID548959Antioxidant activity against AAPH-induced lipid peroxidation assessed as inhibition of conjugated diene hydroperoxide production at 0.1 mM by UV spectrophotometry2010Bioorganic & medicinal chemistry, Dec-01, Volume: 18, Issue:23
Does conjugation of antioxidants improve their antioxidative/anti-inflammatory potential?
AID343383Inhibition of Crithidia fasciculata trypanothione reductase-substrate complex2008Bioorganic & medicinal chemistry, Jul-15, Volume: 16, Issue:14
The use of natural product scaffolds as leads in the search for trypanothione reductase inhibitors.
AID548960Antioxidant activity of the compound assessed as reducing activity of DPPH at 0.1 mM after 20 mins2010Bioorganic & medicinal chemistry, Dec-01, Volume: 18, Issue:23
Does conjugation of antioxidants improve their antioxidative/anti-inflammatory potential?
AID214649Natural log of the value in (uM) of inhibition constant was tested against Trypanothione Reductase1997Journal of medicinal chemistry, Jul-18, Volume: 40, Issue:15
A virtual screening approach applied to the search for trypanothione reductase inhibitors.
AID548962Cytotoxicity against RAMEC assessed as cell viability after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry, Dec-01, Volume: 18, Issue:23
Does conjugation of antioxidants improve their antioxidative/anti-inflammatory potential?
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (7.41)18.2507
2000's4 (14.81)29.6817
2010's9 (33.33)24.3611
2020's12 (44.44)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.34 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (3.70%)0.25%
Other26 (96.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]